PerformRx/AmeriHealth Mercy to Present at 2005 World Health Care Congress
Philadelphia, PA - Mesfin Tegenu, MS, RPh, Vice President, Pharmacy Services, AmeriHealth Mercy/PerformRx, will moderate a panel on "Best Practices to Manage Pharmaceutical Costs Effectively", on Tuesday, February 1, 2005 at the 2005 World Health Care Congress in Washington, D.C., January 30 -February 1, 2005 at the Marriott Wardman Park Hotel. PerformRx is also a sponsor of the Congress and will exhibit in the Executive Networking Area.
The panel, "Best Practices to Manage Pharmaceutical Costs Effectively - Weighing the Value of Drug Spend vs. Medical Spend", will feature Robert Seidman, Pharm.D., MPH, Vice President, Chief Pharmacy Officer, Healthcare Quality Assurance, WellPoint Health Networks, and Sharad Manskani, MD, Senior Advisor and Medical Officer, Office of Clinical Standards and Quality, Centers for Medicare and Medicaid Services.
PerformRx is the next generation pharmacy benefit management program with a proven pharmacy care management solution that meets financial objectives while improving the quality of health care for its customers. Within the Medicaid sector, by using the approach of linking traditional medical management with pharmacy management, PerformRx maintains an average annual pharmacy cost trend of 5% versus the national trend in the range of 15%.
With more than 20 years of experience exclusively serving the Medicaid population, AmeriHealth Mercy and its affiliates comprise the largest family of Medicaid managed care plans in the United States, touching the lives of more than 1.4 million members in seven states, Pennsylvania, New Jersey, Kentucky, South Carolina, Virginia, California and Arizona. For more information visit AmeriHealth Mercy and PerformRx.
The two-day conference will address the major challenges payors and large self-insured employers are currently facing with managing high-cost, low-volume specialty pharmaceutical market. It will also feature organizations presenting best practices, highlighting ways in which they have managed the rising cost sand surrounding challenges of specialty pharmaceuticals. For more information, visit www.worldcongress.com. |